HIN
Click for more information
0.00% $2.37 heartware international, inc

92% success in pivotal bridge-to-transplant

  1. pat done
    4,131 Posts.
    clock Created with Sketch.
    15/11/10
    02:20
    Post #: 7473539
    HeartWare International has added a news release to its Investor Relations website.
    Title: HeartWare Achieves Primary Endpoint with 92% Success in Pivotal Bridge-to-Transplant Clinical Trial c, ADVANCE

    Date(s): 14-Nov-2010 9:02 AM
    HIN Price at posting: $2.12 Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.